Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-2 superagonists in combination with anti-PD-1 antibodies

IL-2 superagonists in combination with anti-PD-1 antibodies

US Patent 11542312 · Granted Jan 3, 2023

Estimated economic value: $770,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interleukin-4 receptor-binding fusion proteins and uses thereof2025
Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof2025
IL-2 superagonists in combination with anti-PD-1 antibodies2025
IL-2 superagonists in combination with anti-PD-1 antibodies2025
IL-4-fusion formulations for treatment of central nervous system (CNS) tumors2025
Interleukin-2 fusion proteins and uses thereof2023
Interleukin-4 receptor-binding fusion proteins and uses thereof2022
Interleukin-4 receptor-binding fusion proteins and uses thereof2021
Interleukin-2 fusion proteins and uses thereof2020
Interleukin-4 receptor-binding fusion proteins and uses thereof2018
Interleukin-4 receptor-binding fusion proteins and uses thereof2018
Antimicrobial and anti-inflammatory peptides2018